Bemegride solution for injections 0,5%

Bemegride solution for injections 0,5% Medicine

Contraindications

Psychomotor agitation.

Incompatibilities

Synergy with mezaton, caffeine.

Undesirable effects

Nausea, vomiting, muscle twitching, convulsions.

Therapeutic indications

Intoxication with barbiturates, anesthesia, severe hypoxia.

Pharmacotherapeutic group

  • Respiratory stimulants

Special precautions for storage

Keep out of reach of children.

Shelf life of the drug Bemegrid solution for injection 0.5%3 года.

Do not use after the expiration date indicated on the package.

Nature and contents of container

Ampoule with 10 ml of bemegrid solution in saline solution (bemegrid 50 mg), in a package of 10 pcs.

Nosological classification (ICD-10)

  • J96 Respiratory failure, not classified elsewhere
  • T40 Poisoning by drugs and psychodysleptics [hallucinogens]
  • T42. 3 Barbiturate poisoning

Dosage (Posology) and method of administration

Intravenous, slowly 5-10 ml, can be re-administered after 2-3 minutes. For children, the single dose is reduced (in proportion to weight).

ATC - Anatomical and therapeutic chemical classification

R07AB05 Bemegrid